Breaking data on the efficacy and cost-effectiveness of an exclusive human milk diet for premature infants to be presented at the American Academy of Pediatrics 2022 National Conference
Type: Press Releases
Topic(s): Company Conferences and Events Cost Savings / Cost Effectiveness
New peer-reviewed study finds vat pasteurization retains molecular structure of naturally occurring bioactive proteins in human donor milk, similar to raw breast milk
Type: Press Releases
Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Microbiome Pasteurization Quality & Safety
Prolacta Bioscience recognizes nurses caring for fragile infants every day throughout Neonatal Nurses Week and NICU Awareness Month
Type: Press Releases
Topic(s): Company
Prolacta Bioscience celebrated Breastfeeding Awareness Month by recognizing the commitment of NICU parents to their infants’ health
Type: Press Releases
Topic(s): Company Parents
Prolacta Bioscience Appoints Dr. Erin Hamilton Spence as Director of Clinical Education and Professional Development
Type: Press Releases
Topic(s): Company
Multiple peer-reviewed studies show Prolacta’s 100% human milk-based nutritional fortifiers reduce risk of life-threatening comorbidities in premature infants, compared to cow milk-based nutrition
Type: Press Releases
Topic(s): Bronchopulmonary Dysplasia (BPD) Clinical Studies Clinical Studies on Prolact/Humavant CR Company Growth Late-Onset Sepsis Necrotizing Entercolitis (NEC) Retinopathy of Prematurity (ROP)
Prolacta Bioscience introduces its first evidence-based feeding protocol for an exclusive human milk diet in the NICU
Type: Press Releases
Topic(s): Bronchopulmonary Dysplasia (BPD) Company Early Fortification Feeding Intolerance Feeding Protocols Growth Healthcare Professionals Late-Onset Sepsis Length of hospital stay Long-Term outcomes Necrotizing Entercolitis (NEC) Product Retinopathy of Prematurity (ROP)
Prolacta Bioscience appoints David Steinberg as chief financial officer
Type: Press Releases
Topic(s): Company
International Conference on Human Milk Science & Innovation to discuss latest research on bioactivity and neurodevelopment
Type: Press Releases
Topic(s): Clinical Studies Conferences and Events Neurodevelopmental Outcomes Probiotics
